Might reconsider because of the benefits
They could have side effects or drug interactions, so close checking is important
November 9, 2024: Study Finds Ozempic May Lead to Muscle Loss A new study published in The Lancet medical journal found that semaglutide, the active ingredient in Ozempic, may lead to a higher rate of muscle mass loss compared with caloric-restricted weight loss
(PubMed) Ferraro PM, Taylor EN, Gambaro G, Curhan GC
Keywords: Psoriasis, hidradenitis suppurativa, Hailey-Hailey disease, medical dermatology, immunology, acanthosis nigricans Introduction Glucagon-like peptide-1 (GLP-1) agonists are a class of medications that mimic GLP-1, a hormone which belongs to the incretin family
Provider care Medication if prescribed Treatment supplies Expedited shipping Compounded Semaglutide is not FDA-approved